Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
about
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsIL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsDifferentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapyHyaluronan regulates cell behavior: a potential niche matrix for stem cellsUp-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatmentEpithelial cell culture models for the prevention and therapy of clinical breast cancer (Review).Diagnostic value of Wilms tumor 1 and CD44 in Langerhans cell sarcoma: case series of 4 patients.Putative cancer-initiating stem cells in cell culture models for molecular subtypes of clinical breast cancer.Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like propertiesEvidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.Quantitative Relationships Between the Cytotoxicity of Flavonoids on the Human Breast Cancer Stem-Like Cells MCF7-SC and Their Structural Properties.CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer.Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells.Breast cancer stem cells-from origins to targeted therapy.Targeting Stemness: Implications for Precision Medicine in Breast Cancer.Ligand binding to anti-cancer target CD44 investigated by molecular simulations.Cutaneous metastases of breast cancer during adjuvant chemotherapy correlates with increasing CD44+/CD24- and ALDH-1 expression: a case report and literature review.
P2860
Q26748850-5A6482C3-BC95-434D-9689-7CEE2F7567B8Q28393898-1F8D6477-5A8B-4D1C-AA6C-8508A45FCD23Q34237510-440A2EE3-175F-421C-BD96-E54797366518Q34435089-60CB9D16-F6C3-497A-88BB-C557BB908BD9Q35063763-C8743353-3695-4D26-B70C-39A8DCEBB880Q35425337-9298B2B3-74AF-49D0-95A9-E5054AB07927Q35652502-B9631320-141A-4F80-BD3A-43617526A561Q35779448-0C9972CF-ADDA-4EFE-B32D-7F37D9FCB60EQ35832351-39FD828E-1C1C-41AF-A0D2-6C5A1C8EFC9BQ35979751-0C143205-FD88-4479-B851-ECCA34A25877Q35995983-A8D4F790-AF61-40B6-AAED-66F7C17B8CADQ36009181-E8D2C87B-765F-40DA-9417-FE6538CF2C60Q36335412-D9E4672D-F2A1-4110-93CB-312728A175E8Q36412709-B17654DC-FE61-48E3-840A-60D4C7BD9D8AQ37039311-FE44422E-EA7F-4A6E-927D-E8CC3227B09BQ37417591-E7C46F58-81A4-496B-BD7F-EDBD4B1026E3Q37610799-BA4F832E-7832-4F16-B458-B60830878B2BQ38086010-3C3D606A-AB18-4857-BF61-460AE8BE775EQ38920671-531A9E4A-3C7F-46E6-B4A5-9B7169DA4590Q39345457-D0FF0C84-F680-47D6-8C47-D40804163FF1Q39866556-9129CCC3-70E2-4495-8AD5-F3EEBD1B2C5DQ42378449-B0483B52-7172-49CC-8778-9F5A27991E4AQ47138666-3B12FCDA-0311-4C2C-B097-3430B0CC81A0Q49544368-FED62440-B12A-4376-9CA9-33F8DD8F1F55Q53029630-9157C194-18DE-4414-BCA0-47B7024360B2Q53692773-45F8DCD4-0221-40AF-AC09-A7B3D75AEA99
P2860
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@ast
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@en
type
label
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@ast
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@en
prefLabel
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@ast
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@en
P2093
P2860
P356
P1476
Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells
@en
P2093
Duong Thanh Thuy
Nguyen Minh Hoang
Nguyen Thanh Tam
Pham Van Phuc
Phan Kim Ngoc
Phan Lu Chinh Nhan
Truong Hai Nhung
Vuong Gia Tue
P2860
P356
10.2147/OTT.S21431
P407
P577
2011-06-21T00:00:00Z